SEHK

ZTO to Announce Third Quarter Financial Results on Nov 17, 2021 U.S. Eastern Time

Friday, October 22, 2021 - 9:00am

About ZTO Express (Cayman) Inc.

Key Points: 
  • About ZTO Express (Cayman) Inc.
    ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057) ("ZTO" or the "Company") is a leading and fast-growing express delivery company inChina.
  • ZTO provides express delivery service as well as other value-added logistics services through its extensive and reliable nationwide network coverage inChina.
  • ZTO operates a highly scalable network partner model, which the Company believes is best suited to support the significant growth of e-commerce inChina.
  • The Company leverages its network partners to provide pickup and last-mile delivery services, while controlling the mission-critical line-haul transportation and sorting network within the express delivery service value chain.

Antengene Enters into a Research Collaboration & License Option Agreement with LegoChem Biosciences for New Antibody-Drug Conjugate Candidates

Thursday, October 21, 2021 - 9:00am

Under this agreement, the two parties will jointly generate and evaluate ADC candidates using Antengene's antibodies and LCB's next generation ADC technology platform.

Key Points: 
  • Under this agreement, the two parties will jointly generate and evaluate ADC candidates using Antengene's antibodies and LCB's next generation ADC technology platform.
  • Antengene will have an exclusive option to license global rights for the development and commercialization of the resulting ADC candidates.
  • When the option is exercised, LCB will be eligible to receive upfront and milestone payments, as well as tiered royalties.
  • In addition, LCB is eligible to receive a prespecified percentage of any sublicensing income received by Antengene.

CSOP Gold Futures Daily (-1X) Inverse Product (Stock Code: 7374.HK) to List on HKEX

Tuesday, October 19, 2021 - 5:00am

Before 7374.HK, CSOP Gold Futures Daily (2x) Leveraged Product (stock code: 7299.HK) was launched on 5 June, 2020.

Key Points: 
  • Before 7374.HK, CSOP Gold Futures Daily (2x) Leveraged Product (stock code: 7299.HK) was launched on 5 June, 2020.
  • We hope CSOP Gold Futures Daily (2x) Leveraged Product (7299.HK) and CSOP Gold Futures Daily (-1X) Inverse Product (7374.HK) will help investors weather the storm of increasing uncertainties.
  • The Product is a futures and swap-based inverse product investing directly in COMEX Gold Futures.
  • CSOP Gold Futures Daily (2x) Leveraged Product (the Product) is a sub-fund of CSOP Leveraged and Inverse Series II, an umbrella unit trust established under Hong Kong law.

New Oriental to Hold Annual General Meeting on November 18, 2021

Monday, October 18, 2021 - 11:00am

BEIJING, Oct. 18, 2021 /PRNewswire/ -- New Oriental Education & Technology Group Inc. ("New Oriental" or the "Company") (NYSE: EDU and SEHK: 9901), a provider of private educational services in China, today announced that it will hold its annual general meeting of shareholders at No.

Key Points: 
  • BEIJING, Oct. 18, 2021 /PRNewswire/ -- New Oriental Education & Technology Group Inc. ("New Oriental" or the "Company") (NYSE: EDU and SEHK: 9901), a provider of private educational services in China, today announced that it will hold its annual general meeting of shareholders at No.
  • No proposal will be submitted for shareholder approval at the annual general meeting.
  • Instead, the annual general meeting will serve as an open forum for shareholders of record and beneficial owners of the Company's American depositary shares ("ADSs") to discuss Company affairs with management.
  • Beneficial owners of the Company's ADSs are welcome to attend the annual general meeting in person.

Antengene to Present Data of Its PD-L1/4-1BB Bispecific Antibody ATG-101 and ERK1/2 Inhibitor ATG-017 at SITC 2021

Friday, October 15, 2021 - 6:28am

The event is dedicated to promoting exchanges and collaborations in the field in order to improve treatment outcomes for cancer patients.

Key Points: 
  • The event is dedicated to promoting exchanges and collaborations in the field in order to improve treatment outcomes for cancer patients.
  • At this year's event, Antengene will release data of its PD-L1/4-1BB bispecific antibody, ATG-101, and its ERK1/2 inhibitor, ATG-017, in poster presentations both online and offline.
  • ATG-101 can activate anti-tumor immune effectors by simultaneously blocking the binding of PD-L1/PD-1 and inducing 4-1BB stimulation.
  • Antengene aims to provide the most advanced anti-cancer drugs to patients in the Asia Pacific Region and around the world.

iClick Unleashes Enormous Market Potential of Cross-border E-commerce for CN Logistics through Launching Mini Program "Vins Mall"

Tuesday, October 12, 2021 - 2:00pm

In this partnership, iClick's innovation centre, the "iClick Lab," teams up with CN logistics to expand capacity into the e-commerce space in China by leveraging CN Logistics' traditional strength in logistics services and strong networking with international brands.

Key Points: 
  • In this partnership, iClick's innovation centre, the "iClick Lab," teams up with CN logistics to expand capacity into the e-commerce space in China by leveraging CN Logistics' traditional strength in logistics services and strong networking with international brands.
  • With its off-the-shelf SaaS product, iSmartGo, together with Marketing Solutions, iClick's offerings address CN Logistics' challenges in acquiring new traffic, boosting revenues over mini program and optimizing consumers lifecycle value with services ranging from tailored mini program establishment, international payment, to targeted marketing initiatives.
  • CN Logistics, meanwhile, has been dedicated to bringing premium wines from worldwide to Hong Kong and the PRC.
  • iClick's mission is to empower worldwide brands to unlock the enormous market potential of smart retail.

Hansoh Pharma and OliX Pharmaceuticals Enter into Licensing and Collaboration Agreement to Develop and Commercialize siRNA Therapeutics in Greater China

Tuesday, October 12, 2021 - 12:00pm

Hansoh will have exclusive commercial rights to these therapeutics in Greater China and OliX will have rights in the rest of the world.

Key Points: 
  • Hansoh will have exclusive commercial rights to these therapeutics in Greater China and OliX will have rights in the rest of the world.
  • OliX will receive an initial upfront payment of $6.5 million with up to $450 million plus royalties based on key milestones.
  • OliX Pharmaceuticals innovative GalNAc-asiRNA platform allows us to consider unique gene silencing technology in addressing a broad range of unmet medical needs here in Greater China.
  • Compared to existing siRNA therapeutics, OliX Pharmaceuticals asiRNA shows comparable gene silencing and significantly reduced siRNA-mediated side effects such as off-target gene silencing and immune stimulation.

EC Healthcare expects to achieve a record-high sales volume in first half of FY21/22

Monday, October 11, 2021 - 12:08am

We believe that the upcoming consumption will further rebound after the re-open of the border between mainland China and Hong Kong.

Key Points: 
  • We believe that the upcoming consumption will further rebound after the re-open of the border between mainland China and Hong Kong.
  • EC Healthcare is Hong Kong's largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services.
  • The move, which is supported by the Group's high-end branding and quality customer services, is aimed at offering customers safe and effective healthcare and medical services with professionalism.
  • The Group principally engages in the provision of one-stop medical and health care services in Greater China.

CNOOC Limited Announces A Large-sized Discovery of Kenli 10-2 in Bohai

Thursday, September 30, 2021 - 5:06am

HONG KONG, Sept. 30,2021 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883, NYSE: CEO, TSX: CNU) announced today that the Company made a large-sized discovery of Kenli 10-2 in Bohai.

Key Points: 
  • HONG KONG, Sept. 30,2021 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883, NYSE: CEO, TSX: CNU) announced today that the Company made a large-sized discovery of Kenli 10-2 in Bohai.
  • The Kenli 10-2 oilfield is located in Laizhou Bay Sag in Southern Bohai Bay, with an average water depth of about 15.7 meters.
  • The main oil-bearing formation of Kenli 10-2 oilfield is in the lower member of Neogene Minghuazhen Formation and the oil properties are conventional heavy oil.
  • The discovery well Kenli 10-2-4 was drilled and completed at a depth of 1,520 meters, and encountered oil pay zones with a total thickness of approximately 27 meters.

CITIC Telecom CPC Partners With Zscaler To Launch Cloud-Native TrueCONNECT(TM) SASE Service To Secure Expanding SD-WAN Edge

Thursday, September 30, 2021 - 3:22am

HONG KONG, Sept 30, 2021 - (ACN Newswire) - CITIC Telecom International CPC Limited ("CITIC Telecom CPC"), a wholly-owned subsidiary of CITIC Telecom International Holdings Limited (SEHK: 1883), is partnering with Zscaler, the leader in cloud security, to launch TrueCONNECT(TM) SASE Service.

Key Points: 
  • HONG KONG, Sept 30, 2021 - (ACN Newswire) - CITIC Telecom International CPC Limited ("CITIC Telecom CPC"), a wholly-owned subsidiary of CITIC Telecom International Holdings Limited (SEHK: 1883), is partnering with Zscaler, the leader in cloud security, to launch TrueCONNECT(TM) SASE Service.
  • The new cloud-native Secure Access Service Edge (SASE) integrates with the Zscaler Zero Trust Exchange(TM) Platform to keep expanding network edges secure.
  • The integration of TrueCONNECT(TM) SASE Service with the Zscaler Zero Trust Exchange(TM) offers users holistic protection for the entire SD-WAN network topologies.
  • CITIC Telecom CPC TrueCONNECT(TM) SASE solution is a cloud-native SASE service that integrates with the Zscaler Zero Trust Exchange(TM).